|
Exempt Reporting Adviser
2B(3)- PF>150mn
|
|
| Private Fund GAV* | 0 -100% |
| SMA’s | No |
| Private Funds | 0 1 |
| Stock Ticker | Stock Name | $ Position | % Position | $ Change | # Change |
|---|---|---|---|---|---|
| Stck Ticker92337C203 | Stock NameVERASTEM INC | $ Position$12,795,575 | % Position7.00% | $ Change-27.00% | # Change1.00% |
| Stck Ticker30052C107 | Stock NameEVOLUS INC | $ Position$11,035,724 | % Position6.00% | $ Change53.00% | # Change-10.00% |
| Stck Ticker640268306 | Stock NameNEKTAR THERAPEUTICS | $ Position$8,422,856 | % Position5.00% | $ Change38.00% | # Change42.00% |
| Stck Ticker88032L605 | Stock NameTENAX THERAPEUTICS INC | $ Position$9,603,000 | % Position5.00% | $ Change-38.00% | # Change-32.00% |
| Stck Ticker000899104 | Stock NameADMA BIOLOGICS INC (CALL) | $ Position$7,950,000 | % Position4.00% | $ Change-23.00% | # Change-43.00% |
| Stck Ticker000899104 | Stock NameADMA BIOLOGICS INC | $ Position$6,193,800 | % Position3.00% | $ Change-7.00% | # Change0.00% |
| Stck Ticker29014R301 | Stock NameELOXX PHARMACEUTICALS INC | $ Position$5,512,581 | % Position3.00% | $ Change | # Change |
| Stck Ticker13463J101 | Stock NameCAMP4 THERAPEUTICS CORP | $ Position$6,072,648 | % Position3.00% | $ Change-1.00% | # Change0.00% |
| Stck Ticker457669307 | Stock NameINSMED INC (CALL) | $ Position$5,600,000 | % Position3.00% | $ Change | # Change |
| Stck Ticker48669G303 | Stock NameKAZIA THERAPEUTICS LTD | $ Position$4,860,120 | % Position3.00% | $ Change89.00% | # Change0.00% |